Panacea Life Sciences, Inc. Launches Innovative New CBD Horse Paste
GOLDEN, CO / ACCESSWIRE / April 12, 2022 / Panacea Life Sciences, Inc. (OTCQB:PLSH), ("Panacea" or the "Company"), a Colorado,...
Day: April 12, 2022
Net Medical Beefing Up Clinical Trial Programs, Announces New Head of Company’s Variant Detection Program
Leaning on two decades of experience connecting providers with the patients who need them, Net Medical's business is unique and...
SURE Retractors Inc. Appoints Vince Proffitt to Board of Directors
SUNRISE, FL / ACCESSWIRE / April 12, 2022 / With the completion of SURE's recent $1.5M seed financing, SURE has...
Secarna Pharmaceuticals’ Strategic Partner Evotec Achieves Programme Designation in Neuroscience Collaboration with Bristol Myers Squibb
The programme designation is based on an antisense-based approach which triggers a US$ 16 M payment to Evotec by Bristol...
APVO442 Prostate Cancer Data Presented at the American Association for Cancer Research Annual Meeting
Preclinical Data Support Potential for APVO442 in Difficult-to-Treat Types of Prostate Cancer, Including Metastatic Castration-Resistant DiseaseSEATTLE, WA / ACCESSWIRE /...
Altamira Therapeutics Provides Business Update and Reports Second Half and Full Year 2021 Financial Results
Management will host an investor conference call today, Tuesday, at 8 a.m. Eastern.Company pivots towards RNA therapeutics and its OligoPhore™...
Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research
• Complementary businesses combine to create a preeminent North American platform with operations spanning 13 wellness clinics, four research sites...
Rakovina Therapeutics Presents Preclinical Data Supporting Potential Broad Anticancer Activity of kt-4000 Series at the American Association of Cancer Research (AACR) Annual General Meeting
VANCOUVER, British Columbia, April 12, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“the Company”), a biopharmaceutical company committed...
Icario Names Healthcare Veteran Troy Jelinek Chief Commercial Officer
Former UnitedHealth Group Executive to Help Lead Growth in Health Plan and Provider MarketsMINNEAPOLIS, April 12, 2022 (GLOBE NEWSWIRE) --...
XP Health Partners With Noyo to Effortlessly Connect with Benefits Administration Platforms and Insurance Carriers, Securely and at Scale
XP Health’s AI-powered Vision Platform to Deliver Enhanced Group Benefits with Noyo IntegrationSAN CARLOS, Calif. and SAN FRANCISCO, April 12, 2022...
Progenity to Become Biora Therapeutics as it Completes Transformation
Upcoming Change Reflects the Company’s Focus on Oral Delivery of BiotherapeuticsSAN DIEGO, April 12, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc....
Cannabix Technologies to Present at International Association for Chemical Testing (IACT) Conference in Arizona
Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safetyVANCOUVER, British Columbia,...
Healthy Extracts Expects Q1 2022 Net Revenue up 187% to Record $489,000, Driving First Profitable Quarter
LAS VEGAS, April 12, 2022 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator of clinically proven plant-based...
Ocugen, Inc. Provides Update on its Phase 2/3 Study of COVAXIN™ (BBV152)
MALVERN, Pa., April 12, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and...
CytoDyn Announces Publication of Peer-Reviewed Paper, “Suppression of Human and Simian Immunodeficiency Virus Replication with the CCR5-Specific Antibody Leronlimab in Two Species”
VANCOUVER, Washington, April 12, 2022 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company...
IO Biotech Announces Initiation of Phase 2 Trial of IO102-IO103 in Combination With KEYTRUDA® (pembrolizumab) as First-Line Treatment in a Multi-Arm Basket Trial
NEW YORK, April 12, 2022 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer...
Halo Elevate Officially Hits Shelves at Pet Supplies Plus
Halo’s Ground-Breaking Brand of Super Premium, Natural Pet Food will be Available at 600+ Pet Supplies Plus Locations Beginning in...
Panbela Announces Poster Presentation at American Association for Cancer Research:
The potential of spermine analogue SBP-101 (diethyl dihydroxyhomospermine) as a polyamine metabolism modulator in ovarian cancerMINNEAPOLIS, April 12, 2022 (GLOBE...
Allogene Therapeutics Announces Participation in Seven Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., April 12, 2022 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering...
Celsion Corporation to Highlight its PLACCINE Platform Technology During Oral Presentation at the World Vaccine Congress
LAWRENCEVILLE, N.J., April 12, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ:CLSN), a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines,...